Dencatistat - Step Pharma
Alternative Names: CTPS1 inhibitor - Step Pharma; STP 938Latest Information Update: 04 Sep 2025
At a glance
- Originator Step Pharma
- Class Anti-inflammatories; Antineoplastics; Antirheumatics; Antithrombotics; Small molecules
- Mechanism of Action Cytidine triphosphate synthetase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase I/II B-cell lymphoma; T-cell lymphoma
- Phase I Solid tumours; Thrombocytosis
- Preclinical Graft-versus-host disease
- No development reported Inflammation; Rheumatoid arthritis
Most Recent Events
- 04 Sep 2025 Chemical structure information added.
- 28 Jul 2025 No recent reports of development identified for preclinical development in Inflammation in France (PO)
- 28 Jul 2025 No recent reports of development identified for preclinical development in Rheumatoid-arthritis in France (PO)